Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "PMSMA"

2 News Found

Ten years on, PMSMA continues to shape safer motherhood in India
Policy | June 10, 2026

Ten years on, PMSMA continues to shape safer motherhood in India

7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines

Progress under “PM Surakshit Matritva Abhiyan”
Policy | December 12, 2022

Progress under “PM Surakshit Matritva Abhiyan”

Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs

Upcoming E-conference
June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

GSK bets big on oncology with $10.6 billion Nuvalent acquisition

Ten years on, PMSMA continues to shape safer motherhood in India

AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Our D2 lamp portfolio caters to entire spectrum of chromatography and spectroscopy customers: Hemang Jhaveri, Partner, Hiten Techno Products Corporation
Our D2 lamp portfolio caters to entire spectrum of chromatography and spectroscopy customers: Hemang Jhaveri, Partner, Hiten Techno Products Corporation
From bench to work flow, we are an integrated solution provider: K.O. Satish, Associate Vice President, Spinco Biotech
From bench to work flow, we are an integrated solution provider: K.O. Satish, Associate Vice President, Spinco Biotech
Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences
Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences
Dr. Ramesh Hariharan Chief Executive Officer, Strand Life Sciences

Packaging